BISERIS Trademark

Trademark Overview

On Wednesday, November 1, 2006, a trademark application was filed for BISERIS with the United States Patent and Trademark Office. The USPTO has given the BISERIS trademark a serial number of 79033691. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 1, 2016. This trademark is owned by Novartis AG. The BISERIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular and metabolic systems including diabetes, the respiratory system, musculo-skeletal and inflammatory disorders, the genitourinary system, for use in dermatology, oncology, hematology, ophthalmology and transplantation; pharmaceutical preparations for use in the gastroenterological area and for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, antibiotics, antifungals and vaccines
biseris

General Information

Serial Number79033691
Word MarkBISERIS
Filing DateWednesday, November 1, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 1, 2016
Registration Number3307624
Registration DateTuesday, October 9, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular and metabolic systems including diabetes, the respiratory system, musculo-skeletal and inflammatory disorders, the genitourinary system, for use in dermatology, oncology, hematology, ophthalmology and transplantation; pharmaceutical preparations for use in the gastroenterological area and for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, antibiotics, antifungals and vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 16, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type98 - Unknown
AddressCH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, June 2, 2017NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, June 2, 2017DEATH OF INTERNATIONAL REGISTRATION
Friday, July 3, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Friday, June 12, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, June 12, 2015INVALIDATION PROCESSED
Friday, January 16, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 16, 2014CANCELLED SECTION 71
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 9, 2009CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, March 26, 2009NEW REPRESENTATIVE AT IB RECEIVED
Thursday, January 8, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 24, 2008FINAL DISPOSITION NOTICE SENT TO IB
Thursday, January 24, 2008FINAL DISPOSITION PROCESSED
Wednesday, January 16, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, January 2, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 2, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 9, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, July 24, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2007NOTICE OF PUBLICATION
Monday, May 7, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 7, 2007ASSIGNED TO LIE
Tuesday, April 17, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 17, 2007EXAMINER'S AMENDMENT ENTERED
Tuesday, April 17, 2007EXAMINERS AMENDMENT E-MAILED
Tuesday, April 17, 2007EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 4, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 4, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 5, 2007REFUSAL PROCESSED BY IB
Thursday, March 15, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 15, 2007REFUSAL PROCESSED BY MPU
Wednesday, March 14, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 13, 2007NON-FINAL ACTION WRITTEN
Monday, March 12, 2007ASSIGNED TO EXAMINER
Friday, February 9, 2007LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, February 8, 2007NEW APPLICATION ENTERED IN TRAM
Thursday, February 8, 2007SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

biseris system disorders preparations prevention anti pharmaceutical treatment area ocular diseases